du Sert, O. P. et al. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial. Schizophr Res, doi:10.1016/j.schres.2018.02.031 (2018).
Dellazizzo, L. et al. Exploration of the dialogue components in Avatar Therapy for schizophrenia patients with refractory auditory hallucinations: A content analysis. Clin Psychol Psychother 25, 878-885, doi:10.1002/cpp.2322 (2018).
Dellazizzo, L., Potvin, S., Phraxayavong, K., Lalonde, P. & Dumais, A. Avatar Therapy for Persistent Auditory Verbal Hallucinations in an Ultra-Resistant Schizophrenia Patient: A Case Report. Front Psychiatry 9, 131, doi:10.3389/fpsyt.2018.00131 (2018).
Dellazizzo, L. et al. Avatar Therapy for persistent auditory verbal hallucinations: a case report of a peer research assistant on his path toward recovery. Psychosis 10, 213-219, doi:10.1080/17522439.2018.1499799 (2018).
Dellazizzo, L., Potvin, S., Bahig, S. & Dumais, A. Comprehensive review on virtual reality for the treatment of violence: implications for youth with schizophrenia. npj Schizophrenia 5, 11, doi:10.1038/s41537-019-0079-7 (2019).
Dellazizzo, L., Potvin, S., Phraxayavong, K. & Dumais, A. Exploring the benefits of Virtual Reality-assisted Therapy following cognitive-behavioral therapy for auditory hallucinations in patients with treatment-resistant schizophrenia: A proof of concept. Journal of Clinical Medicine. (2020).
Dellazizzo, L., Potvin, S., Luigi, M. & Dumais, A. Evidence on Virtual Reality–Based Therapies for Psychiatric Disorders: Meta-Review of Meta-Analyses. J Med Internet Res 22, e20889, doi:10.2196/20889 (2020).
Dellazizzo, L., Potvin, S., Phraxayavong, K. & Dumais, A. One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. npj Schizophrenia. doi:10.1038/s41537-021-00139-2 (2021).
Dellazizzo, L. et al. [Improving Quality of Life in Patients with Refractory Schizophrenia After Virtual Reality-assisted Therapy: A Content Analysis]. Sante mentale au Quebec 46, 157-174 (2021).
Beaudoin, M. et al. The therapeutic processes of avatar therapy: A content analysis of the dialogue between treatment-resistant patients with schizophrenia and their avatar. Clinical Psychology & Psychotherapy 28, 500-518, doi:https://doi.org/10.1002/cpp.2556 (2021).
Dellazizzo, L., Potvin, S., Phraxayavong, K., Giguère, S., Hamidi, L.N., et Dumais, A. (2021) L’amélioration de la qualité de vie chez les patients atteints d’une schizophrénie réfractaire ayant suivi la Thérapie assistée par la Réalité Virtuelle : une analyse de contenu. Santé mentale au Québec. 46 1: 157-174.
Athanassiou M, Dumais A, Gnanhoue G, Abdel-Baki A, Jutras-Aswad D, Potvin S (2021). A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders. Expert Review of Neurotherapeutics. 2021 Mar https://doi.org/10.1080/14737175.2021.1942845
Hudon, A., Beaudoin, M., Phraxayavong, K., Dellazizzo, L., Potvin, S., et Dumais, A. (2021). Use of Automated Thematic Annotations for Small Data Sets in a Psychotherapeutic Context: Systematic Review of Machine Learning Algorithms. JMIR Ment Health. Review. 8 10: 22651. (DOI: 10.2196/22651)
Dellazizzo, L., Potvin, S., Giguère S. & Dumais A (2022). Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: A systematic meta-review of meta-analyses. Addiction. (doi: 10.1111/add.15764. Online ahead of print.)
Dellazizzo L, Potvin S, Giguère S, Dumais A. The Potential Paradoxical Neurocognitive Effects of Cannabis Use in Patients with Psychotic Disorders: A Critical Meta-Review of Meta-Analytical Evidence. Cannabis Cannabinoid Res. 2022 Jun 3. doi: 10.1089/can.2021.0163. Online ahead of print. PMID: 35666226
Beaudoin M, Hudon A, Giguère CE, Potvin S, Dumais A. Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. NPJ Schizophr. 2022 Mar 21;8(1):29. doi: 10.1038/s41537-022-00236-w.PMID: 35314708
Dumais A. et al. A systematic review of relational-based therapies for the treatment of auditory hallucinations in patients with psychotic disorders. Psychological Medicine. 2022. DOI: 10.1017/S003329172200143X
Hudon A, Lammatteo V, Rodrigues-Coutlée S, Dellazizzo L, Giguère S, Phraxayavong K, Potvin S, and Dumais A. (2023). Exploration of the role of emotional expression of treatment-resistant schizophrenia patients having followed virtual reality therapy: a content analysis. BMC Psychiatry. 12;23(1):420. doi: 10.1186/s12888-023-04861-2.
Giguère S, Potvin S. Beaudoin M, Dellazizzo L, Giguère C.-É, Furtos A, Gilbert K, Phraxayavong K and Dumais A. (2023). Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study. Journal of Personalized Medicine. 13, 766. https://doi.org/10.3390/jpm13050766
Giguère S, Dellazizzo L, Beaudoin M, Lapierre M-A, Villeneuve M, Phraxayavong K, Potvin S, and Dumais A. (2023). Avatar Intervention for the treatment of cannabis use disorder on patient with schizoaffective disorder: A case report. BioMedInformatics. 3, 1112–1123.
Augustin E, Beaudoin M, Giguère S, Ziady H, Phraxayavong K et Dumais A. (2024). The Relationship between Sense of Presence, Emotional Response, and Clinical Outcomes in Virtual Reality-Based Therapy for Treatment-Resistant Schizophrenia: A Correlational Study. Journal of Personalized Medicine. 14(6), 614. doi: 10.3390/jpm14060614.
Giguère S, Beaudoin M, Dellazizzo L, Phraxayavong K, Potvin, S and Dumais, A. (2024). Avatar Intervention in Virtual Reality for Cannabis Use Disorder in Individuals With Severe Mental Disorders: Results From a 1-Year, Single-Arm Clinical Trial. JMIR Mental Health, 11(1), e58499.
Giguère S, Beaudoin M, Dellazizzo L, Phraxayavong K, Potvin S, and Dumais A. Reattribution of Auditory Hallucinations Throughout Avatar Therapy: A Case Series. Reports 2025, 8, 113. https://doi.org/10.3390/reports8030113